Product Information
PHENOBARBITAL 64.8 MG TABLET is a generic product labeled by e5 Pharma, LLC, priced at $0.0971 per EA under NDC 13517062701. Its NADAC has been published 185 times since Feb 8, 2023.
Strength
64.8 mg/1
Manufacturer
e5 Pharma, LLCNDC
13517062701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/30/2022
Price Statistics
The NADAC for PHENOBARBITAL 64.8 MG TABLET has been published 185 times since Feb 8, 2023, and over the history we have for it it has declined 68.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0971 per EA |
|---|---|
| All-time high | $0.3176 (Aug 16, 2023) |
| All-time low | $0.0928 (Jul 22, 2026) |
| 52-week high | $0.1607 |
| 52-week low | $0.0928 |
| Median price | $0.1495 |
| Average price | $0.1776 |
| Largest weekly change | +98.1% (Aug 21, 2024) |
| Weeks tracked | 185 |
| Tracking since | Feb 8, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 64.8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 64.8 MG TABLET, manufactured by e5 Pharma, LLC, is $0.0971 per EA (NDC 13517062701), effective Aug 19, 2026.
How has the price of PHENOBARBITAL 64.8 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 64.8 MG TABLET has declined 68.9%. It has been tracked across 185 weekly CMS publications since Feb 8, 2023.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 64.8 MG TABLET?
Since Feb 8, 2023, the NADAC for PHENOBARBITAL 64.8 MG TABLET has ranged from a low of $0.0928 (Jul 22, 2026) to a high of $0.3176 (Aug 16, 2023), with a median of $0.1495 per EA.
Are there cheaper alternatives to PHENOBARBITAL 64.8 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 64.8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 64.8 MG TABLET?
PHENOBARBITAL 64.8 MG TABLET (NDC 13517062701) is labeled by e5 Pharma, LLC, and CMS classifies it as a generic product.